(Q38021339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Thomas S Uldrick

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Robert Yarchoan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Oncology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

495-505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

Antibodies to human herpesvirus 8 in POEMS (polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes) syndrome with multicentric Castleman's disease

6 February 2020

cites work

1 reference

12 December 2020

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

12 December 2020

Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir

1 reference

12 December 2020

Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease

1 reference

12 December 2020

Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

1 reference

12 December 2020

Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins

1 reference

12 December 2020

KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways

1 reference

12 December 2020

Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir

1 reference

12 December 2020

HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma

1 reference

12 December 2020

Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.

1 reference

12 December 2020

Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node

1 reference

12 December 2020

The restricted cellular host range of human herpesvirus 8.

1 reference

12 December 2020

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

1 reference

12 December 2020

Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha

1 reference

12 December 2020

Mucosal shedding of human herpesvirus 8 in men.

1 reference

12 December 2020

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays

1 reference

12 December 2020

Structure of an extracellular gp130 cytokine receptor signaling complex

1 reference

12 December 2020

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

1 reference

12 December 2020

Treatment of HIV-associated multicentric Castleman's disease with oral etoposide

1 reference

12 December 2020

Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis

1 reference

12 December 2020

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

1 reference

12 December 2020

Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus

1 reference

12 December 2020

Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma

1 reference

12 December 2020

Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.

1 reference

12 December 2020

Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review

1 reference

12 December 2020

Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells

1 reference

12 December 2020

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease

1 reference

12 December 2020

Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival

1 reference

12 December 2020

Role of IL-10 for induction of anemia during inflammation

1 reference

12 December 2020

Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line

1 reference

12 December 2020

Viral IL-6-induced cell proliferation and immune evasion of interferon activity

1 reference

12 December 2020

A pilot study of cidofovir in patients with kaposi sarcoma

1 reference

12 December 2020

Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease

1 reference

12 December 2020

Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide

1 reference

12 December 2020

Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients

1 reference

12 December 2020

CASE records of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 40011

1 reference

12 December 2020

Localized mediastinal lymphnode hyperplasia resembling thymoma

1 reference

12 December 2020

Lymphokine production by B cells from normal and HIV-infected individuals

1 reference

12 December 2020

Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms

1 reference

12 December 2020

Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment

1 reference

12 December 2020

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma

1 reference

12 December 2020

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

12 December 2020

Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma

1 reference

12 December 2020

Failure of cidofovir in HIV-associated multicentric Castleman disease

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism

1 reference

12 December 2020

Quantification of Kaposi's Sarcoma-Associated Herpesvirus in Blood, Oral Mucosa, and Saliva in Patients with Kaposi's Sarcoma

1 reference

12 December 2020

Atypical cellular disorders

1 reference

12 December 2020

Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir

1 reference

12 December 2020

Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression

1 reference

12 December 2020

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

1 reference

12 December 2020

Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease

1 reference

12 December 2020

Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease

1 reference

12 December 2020

Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family

1 reference

12 December 2020

DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages

1 reference

12 December 2020

Oral EBV and KSHV infection in HIV.

1 reference

12 December 2020

Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma

1 reference

12 December 2020

Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease

1 reference

12 December 2020

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma

1 reference

12 December 2020

Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men.

1 reference

12 December 2020

Virus-associated tumor imaging by induction of viral gene expression

1 reference

12 December 2020

The C type lectins DC-SIGN and L-SIGN: receptors for viral glycoproteins

1 reference

12 December 2020

1 reference

12 December 2020

Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells

1 reference

12 December 2020

Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial

1 reference

12 December 2020

1 reference

12 December 2020

Relationship between the Quantity of Kaposi Sarcoma–Associated Herpesvirus (KSHV) in Peripheral Blood and Effusion Fluid Samples and KSHV‐Associated Disease

1 reference

12 December 2020

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

1 reference

12 December 2020

Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

1 reference

12 December 2020

Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.

1 reference

12 December 2020

Multicentric Castleman's disease in HIV infection: a systematic review of the literature

1 reference

12 December 2020

Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure

1 reference

12 December 2020

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases

1 reference

12 December 2020

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling

1 reference

12 December 2020

Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection

1 reference

12 December 2020

HIV-associated lymphomas and gamma-herpesviruses.

1 reference

12 December 2020

Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD)

1 reference

12 December 2020

Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6

1 reference

12 December 2020

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

1 reference

12 December 2020

The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

1 reference

12 December 2020

X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions

1 reference

12 December 2020

Castleman disease: an update on classification and the spectrum of associated lesions

1 reference

12 December 2020

Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells

1 reference

12 December 2020

CD20 expression in the HHV-8-infected lymphoid cells in multicentric Castleman disease

1 reference

12 December 2020

An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization

1 reference

12 December 2020

Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes

1 reference

12 December 2020

Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA

1 reference

12 December 2020

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma

1 reference

12 December 2020

An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease

1 reference

12 December 2020

Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease

1 reference

12 December 2020

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

1 reference

12 December 2020

Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling

1 reference

12 December 2020

How I treat HIV-associated multicentric Castleman disease

1 reference

12 December 2020

The influence of splenectomy on the infectious complications and outcomes of people with HIV: marked, sustained elevation in risk of severe infection with bacteria including Streptococcus pneumoniae

1 reference

12 December 2020

Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization.

1 reference

12 December 2020

B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection

1 reference

12 December 2020

KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation

1 reference

12 December 2020

Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study

1 reference

12 December 2020

Cancer burden in the HIV-infected population in the United States

1 reference

12 December 2020

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy

1 reference

12 December 2020

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease

1 reference

12 December 2020

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

1 reference

12 December 2020

Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells

1 reference

12 December 2020

POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management

1 reference

12 December 2020

Human herpesvirus 8 seropositivity among sexually active adults in Uganda

1 reference

12 December 2020

Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease

1 reference

12 December 2020

A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice

1 reference

12 December 2020

Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders

1 reference

12 December 2020

Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.

1 reference

12 December 2020

Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells

1 reference

12 December 2020

Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa

1 reference

12 December 2020

Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease

1 reference

12 December 2020

Kaposi's Sarcoma Associated Herpesvirus Entry into Target Cells

1 reference

12 December 2020

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome

1 reference

12 December 2020

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

1 reference

12 December 2020

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

1 reference

12 December 2020

Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS).

1 reference

12 December 2020

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

1 reference

12 December 2020

Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6)

1 reference

12 December 2020

Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

12 December 2020

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

1 reference

12 December 2020

Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice

1 reference

12 December 2020

[Association of Castleman's disease and Hodgkin's disease. Eight cases and review of the literature]

1 reference

12 December 2020

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants.

1 reference

12 December 2020

Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells

1 reference

12 December 2020

Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

1 reference

12 December 2020

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

12 December 2020

Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice

1 reference

12 December 2020

Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients

1 reference

12 December 2020

Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

1 reference

12 December 2020

B-cell-derived IL-10: production and function

1 reference

12 December 2020

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

1 reference

12 December 2020

Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

1 reference

12 December 2020

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

1 reference

12 December 2020

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

1 reference

12 December 2020

Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

1 reference

12 December 2020

Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.

1 reference

12 December 2020

Expression of vascular endothelial growth factor in lymphomas and Castleman's disease

1 reference

12 December 2020

Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease

1 reference

12 December 2020

Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells

1 reference

12 December 2020

10.1097/CCO.0B013E328355E0F3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729151%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference